Priority Date: 20.06.12 (US 201261661971P)

INTERVAL THERAPY FOR THE TREATMENT OF LOSS OF EYESIGHT IN HUMANS WITH GLAUCOMA AND OTHER DEGENERATIVE EYE DISEASES

  • Application ID: EP13730122
  • Status: GRANT OF PATENT INTENDED

Applicant

Company dna ramot at tel aviv university ltd
Technology Transfer Office

Attorney

operating since 1920
1180.81
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 20.06.2012 - Priority Date (US 201261661971P)
  • 27.12.2013 - Publication A2 (WO2013189606)
  • 29.04.2015 - Publication A2 (EP2863935)

IPC Classification